COMPASS Pharma
ActiveSummary
COMPASS Pharma has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €236,480 and a net result of €39,042. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 50% of 39,137 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 26 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
2 establishment units
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 23080D0033/00C000 | Flanders | 2,431 m² | 1 · 155 m² | 6.1 m · 1 |
| 12035E0327/00K000 | Flanders | 416 m² | 1 · 97 m² | - |